Eosinophilic bronchitis is a condition presenting with chronic cough and characterized by sputum eosinophilia (> 3% of non squamous epithelial cells), but unlike asthma there is no evidence of variable airflow obstruction and airways hyperresponsiveness (1, 2) . Exposure to certain occupational allergens or sensitizers, such as natural rubber latex (3), acrylates (4), mushroom spores (5) and an epoxy resin hardener (6) , have been reported to cause eosinophilic bronchitis without asthma. We report the case of a foundry worker and a baker who developed cronic cough as a consequence of occupational exposure respectively to isocyanate and flour.
Case report 1
A 44 years old man working in a foundry for eight years. He used to smoke 10 cigarettes daily and had no history of atopy and asthma. He described his job as making cores and from the safety data sheet he gave us, we realized that he was exposed to MDI. He had never complained of respiratory symptoms since the last six months, when he started suffering a non productive chronic cough without wheezing or dyspnea. The cough worsened at work and improved on week-ends off work or holidays. Physical examination, chest radiography, peripheral blood count were normal. Skin and blood test for allergy, lung function and cellularity of sputum induced after the work shift are shown in table 1. Sputum induction was performed as described by Pin et al. (7) within 6 hours the last exposure at work and the sample examined as described by Pavord et al. (8) . Due to his cough, the worker was relocated by the foundry occupational physician to a new job in the foundry stores where he was not exposed to isocyanate. His cough improved and after a month he was completely asymptomatic. Sputum induction was performed while asymptomatic and after specific bronchial challenge with isocyanate. Specific inhalation challenge with MDI was carried out in a 10 m 3 dynamic chamber. A MDI atmosphere was generated in the chamber by passing dry air trough MDI contained in a flask and injected into the ultrafiltered air stream in the chamber through a Venturi effect. Isocyanate concentration was continuosly monitored with an MDA device (Iso-Check). On the day of the challenge, he was exposed to MDI up to a maximum concentration of 20 ppm for 30 minutes. After the isocyanate challenge he started to have non productive persisting cough, but no changes in FEV1 occurred during the 24 hours observing period. After this period, sputum induction was performed before methacoline challenge. The methacoline challenge was normal at a maximal dose response curve (PD 20 > 3200 ug). Induced sputum percentages of non squamous epithelial cells are shown in table 1.
Case report 2
A 41 year old male baker, non smoker, exposed to flour for 10 years. In the last 2 years he had a non productive cronic cough without wheezing or dyspnea. The cough worsened at work and waned off during holidays. He was prescribed by his general practitioner antitussive medication with a poor response and was not receiving any medication for asthma. Physical examination and a chest radiography (prescribed by the general practitioner 2 months before) were normal. Peripheral blood count was normal . Skin and blood test for allergy, lung function and cellularity of sputum induced after the work shift are shown in table 2. Sputum induction as described by Pin et al. (7), was performed in the morning after his night shift and the sample was processed as described by Pavord et al. (8) . As he had complained occasionally of headache and heartburn, we performed also a sinus radiography as well as a 24-hour gastric Ph monitoring, which were normal then excluding post nasal drip and atypical symptoms of gastroaesophageal reflux. He continued to work in the family bakery and so we decided to start treatment with inhaled fluticasone (500 ug daily). He had a markedly response to therapy and after a month of treatment he was asymptomatic. After a while, the patient still on treatment and followed up in our outpatient clinic, took a temporary leave from the bakery work. Therefore we decided to stop treatment, advising him to contact us if symptoms would have occurred and to come to our outpatient clinic before he would have started again to bake. During this period he remained asymptomatic. Sputum induction was performed while asymptomatic still exposed at work but on inhaled steroids, while asymptomatic not exposed at work and after flour specific bronchial challenge. 
Discussion
The occupational exposure to isocyanate and flour was the cause of eosinophilic bronchitis respectively in this foundry worker and baker, who were characterized by work related changes in sputum eosinophils significant and reproducible. The causative agents of eosinophilic bronchitis in the worplace have rarely been ascertained. At present, eosinophil bronchitis can be causally related to occupational agents only in the patients described by us and in two other published case reports (3, 4) . Challenge exposure to latex gloves in a nurse (3) and acrylates in the other worker (4) resulted in a marked increase in sputum eosinophilia in the absence of airflow obstruction and bronchial hyperresponsiveness. In a cross-sectional health survey conducted in a mushroom farm (5), eosinophilic bronchitis was among the causes of chronic cough in such an environment, but a causal relationship between a specific occupational agent exposure and the sputum eosinophilia was not reproducibly demonstrated with specific occupational bronchial challenge.
It is not known why these patients do not have airway hyperresponsiveness despite the eosinophilic bronchial inflammation, nor whether they may progress to typical occupational asthma. There is a recent prospective follow up study of patients with eosinophilic bronchitis not related to Table 2 . Skin and blood test for allergy, lung function and induced sputum of baker.
*(House dust mites, pollens, cat and dog dander, molds as Alternaria alternata, Aspergillus fumigatus and Cladosporium herbarum). **Skin prick test positivity a wheal diameter of 5 mm, more than one half of that of histamine control. # Peak expiratory flows measured six times daily for 4 weeks without significant changes at work or away from work.
# # Methacoline challenge performed soon after the work shift (in the morning after the night shift) at a maximal dose response curve. 
